220 related articles for article (PubMed ID: 23527666)
1. Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
Sandoval M; Coleman P; Govani R; Siddiqui S; Todd KH
J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):10-8. PubMed ID: 23527666
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
3. The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness.
Thomas JR; Wallace MS; Yocum RC; Vaughn DE; Haller MF; Flament J
J Pain Symptom Manage; 2009 Nov; 38(5):663-72. PubMed ID: 19819665
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain.
Chang AK; Bijur PE; Davitt M; Gallagher EJ
Ann Emerg Med; 2009 Oct; 54(4):561-567.e2. PubMed ID: 19560838
[TBL] [Abstract][Full Text] [Related]
5. The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers.
Thomas JR; Yocum RC; Haller MF; Flament J
J Pain Symptom Manage; 2009 Nov; 38(5):673-82. PubMed ID: 19819667
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of patient-controlled analgesia for patients with acute abdominal pain in the emergency department: a randomized trial.
Birnbaum A; Schechter C; Tufaro V; Touger R; Gallagher EJ; Bijur P
Acad Emerg Med; 2012 Apr; 19(4):370-7. PubMed ID: 22506940
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial.
Chang AK; Bijur PE; Meyer RH; Kenny MK; Solorzano C; Gallagher EJ
Ann Emerg Med; 2006 Aug; 48(2):164-72. PubMed ID: 16857467
[TBL] [Abstract][Full Text] [Related]
9. Effective analgesia with low-dose ketamine and reduced dose hydromorphone in ED patients with severe pain.
Ahern TL; Herring AA; Stone MB; Frazee BW
Am J Emerg Med; 2013 May; 31(5):847-51. PubMed ID: 23602757
[TBL] [Abstract][Full Text] [Related]
10. Nebulized fentanyl vs intravenous morphine for ED patients with acute limb pain: a randomized clinical trial.
Farahmand S; Shiralizadeh S; Talebian MT; Bagheri-Hariri S; Arbab M; Basirghafouri H; Saeedi M; Sedaghat M; Mirzababai H
Am J Emerg Med; 2014 Sep; 32(9):1011-5. PubMed ID: 25027194
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of intravenous patient-controlled remifentanil versus morphine anesthesia after coronary artery surgery.
Baltali S; Turkoz A; Bozdogan N; Demirturk OS; Baltali M; Turkoz R; Arslan G
J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):170-4. PubMed ID: 18834819
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial of the 2 mg hydromorphone bolus protocol versus the "1+1" hydromorphone titration protocol in treatment of acute, severe pain in the first hour of emergency department presentation.
Chang AK; Bijur PE; Lupow JB; Gallagher EJ
Ann Emerg Med; 2013 Oct; 62(4):304-10. PubMed ID: 23694801
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing a fascia iliaca compartment nerve block to a traditional systemic analgesic for femur fractures in a pediatric emergency department.
Wathen JE; Gao D; Merritt G; Georgopoulos G; Battan FK
Ann Emerg Med; 2007 Aug; 50(2):162-71, 171.e1. PubMed ID: 17210208
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.
Wermeling DP; Clinch T; Rudy AC; Dreitlein D; Suner S; Lacouture PG
J Pain; 2010 Jan; 11(1):24-31. PubMed ID: 19592310
[TBL] [Abstract][Full Text] [Related]
17. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
Telfer P; Bahal N; Lo A; Challands J
Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
[TBL] [Abstract][Full Text] [Related]
18. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
[TBL] [Abstract][Full Text] [Related]
19. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
McCormick Z; Chu SK; Chang-Chien GC; Joseph P
Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
[TBL] [Abstract][Full Text] [Related]
20. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
